Neurocrine Biosciences
NBIX
NBIX
117 hedge funds and large institutions have $547M invested in Neurocrine Biosciences in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 34 increasing their positions, 43 reducing their positions, and 27 closing their positions.
Holders
117
Holders Change
-5
Holders Change %
-4.1%
% of All Funds
3.4%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
22
Increased
34
Reduced
43
Closed
27
Calls
$6.31M
Puts
$1.11M
Net Calls
+$5.2M
Net Calls Change
-$26K
Top Buyers
1 |
O
1
OrbiMed
New York
|
$24.6M |
2 |
2
Millennium Management
New York
|
$7.76M |
3 |
BB
3
BB Biotech
Schaffhausen,
Switzerland
|
$24.7M |
4 |
![]()
4
Franklin Resources
San Mateo,
California
|
$19.6M |
5 |
5
Invesco
Atlanta,
Georgia
|
$7.6M |